Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial

Manan Pareek; Mats C Højbjerg Lassen; Niklas Dyrby Johansen; Sine H Christensen; Negar Aliabadi; Kristoffer G Skaarup; Daniel Modin; Brian L Claggett; Maj Beldring Henningsen; Carsten S Larsen; Lykke Larsen; Lothar Wiese; Michael Dalager-Pedersen; Matias G Lindholm; Anne Marie R Jensen; Maria Dons; Katrine F Bernholm; Filip S Davidovski; Lisa S Duus; Camilla I Ottosen; Anne B Nielsen; Julie H Borchsenius; Caroline Espersen; Güldas Köse; Frederik H Fussing; Lars Køber; Scott D Solomon; Jens Ulrik Stæhr Jensen; Cyril Jean-Marie Martel; Bradford D Gessner; Claudia Schwarz; Mette Skovdal; Pingping Zhang; Elizabeth Begier; Tor Biering-Sørensen

doi:10.2337/dca26-0020

Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial

Diabetes Care. 2026 Jun 1;49(6):e88-e90. doi: 10.2337/dca26-0020.

Authors

Manan Pareek^{1

2}, Mats C Højbjerg Lassen^{1

2}, Niklas Dyrby Johansen^{1

2}, Sine H Christensen^{1

2}, Negar Aliabadi³, Kristoffer G Skaarup^{1

2}, Daniel Modin^{1

2}, Brian L Claggett⁴, Maj Beldring Henningsen^{1

2}, Carsten S Larsen^{5

6}, Lykke Larsen⁷, Lothar Wiese⁸, Michael Dalager-Pedersen^{9

10}, Matias G Lindholm¹¹, Anne Marie R Jensen^{1

2}, Maria Dons^{1

2}, Katrine F Bernholm^{1

2}, Filip S Davidovski^{1

2}, Lisa S Duus^{1

2}, Camilla I Ottosen^{1

2}, Anne B Nielsen^{1

2}, Julie H Borchsenius^{1

2}, Caroline Espersen^{1

2}, Güldas Köse^{1

2}, Frederik H Fussing^{1

2}, Lars Køber^{12

13}, Scott D Solomon⁴, Jens Ulrik Stæhr Jensen^{12

14}, Cyril Jean-Marie Martel¹⁵, Bradford D Gessner³, Claudia Schwarz³, Mette Skovdal³, Pingping Zhang³, Elizabeth Begier³, Tor Biering-Sørensen^{1

2

13

16}

Affiliations

¹ Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
² Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
³ Pfizer, New York, NY.
⁴ Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
⁵ Department of Clinical Medicine and Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
⁶ European LifeCare Group, Søborg, Denmark.
⁷ Research Unit for Infectious Diseases, Odense University Hospital, Odense, Denmark.
⁸ Department of Infectious Diseases, Zealand University Hospital, Roskilde, Denmark.
⁹ Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.
¹⁰ Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
¹¹ Department of Cardiology, Zealand University Hospital Roskilde, Roskilde, Denmark.
¹² Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
¹³ Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
¹⁴ Respiratory Medicine Section, Department of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
¹⁵ Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
¹⁶ Steno Diabetes Center Copenhagen, Copenhagen, Denmark.

No abstract available

Publication types

Letter

Grants and funding

Pfizer